Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Operating Expenses (2016 - 2026)

Pediatrix Medical (MD) has disclosed Operating Expenses for 17 consecutive years, with $445.0 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 3.91% to $445.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 billion through Dec 2025, down 18.09% year-over-year, with the annual reading at $1.7 billion for FY2025, 18.09% down from the prior year.
  • Operating Expenses for Q4 2025 was $445.0 million at Pediatrix Medical, up from $424.8 million in the prior quarter.
  • The five-year high for Operating Expenses was $662.0 million in Q2 2024, with the low at $409.0 million in Q2 2025.
  • Average Operating Expenses over 5 years is $464.1 million, with a median of $444.0 million recorded in 2022.
  • The sharpest move saw Operating Expenses skyrocketed 46.44% in 2024, then tumbled 38.22% in 2025.
  • Over 5 years, Operating Expenses stood at $430.5 million in 2021, then rose by 10.98% to $477.8 million in 2022, then increased by 27.23% to $607.9 million in 2023, then dropped by 23.83% to $463.1 million in 2024, then fell by 3.91% to $445.0 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $445.0 million, $424.8 million, and $409.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.